Arcam’s new EBM system, Arcam Q10, is developed in close collaboration with leading implant manufacturers and the development is partly financed by Vinnova. The system is designed to meet the implant industry's need for ease of use, productivity, accuracy and quality assurance.
Arcam Q10 replaces Arcam A1, the current industry standard for additive manufacturing of orthopedic implants. The orthopedic market is one of Arcam's two main markets. The EBM technology is used for implant production since 2007, and more than 30.000 EBM-manufactured orthopedic devices have been implanted worldwide. The market share of EBM-manufactured implants is growing steadily.
Arcam Q10 includes several new features for industrial volume production, including increased productivity, higher accuracy, and Arcam LayerQam, a new camera based monitoring system for continuous quality assurance.
- With Arcam Q10 we sharpen our offering to one of our main markets, the implant industry. Arcam Q10 represents a new EBM generation, with a focus on continued industrialization of the technology," says Magnus René, CEO of Arcam, and continues;
- Arcam Q10 strengthens our already strong product program for orthopedic implants, a market that puts high demands on both the technology and the application expertise. The first Arcam Q10 user will be DiSanto Technology Inc. in Shelton, CT, USA, with whom we recently signed a strategic cooperation agreement.